Moneycontrol
HomeNewsIndiaTotal number of Omicron cases in Delhi rises to 165: Govt data
Trending Topics

Total number of Omicron cases in Delhi rises to 165: Govt data

Amid the Omicron scare, Delhi recorded 331 fresh coronavirus cases, the highest single-day rise since June 9 and one death, on Monday, while the positivity rate mounted to 0.68 per cent, according to data shared by the city health department.

December 28, 2021 / 13:31 IST
Story continues below Advertisement

The total number of cases of new Omicron variant of COVID-19 recorded in the national capital has mounted to 165, according to data shared by the Union Health Ministry on Tuesday.

Amid the Omicron scare, Delhi recorded 331 fresh coronavirus cases, the highest single-day rise since June 9 and one death, on Monday, while the positivity rate mounted to 0.68 per cent, according to data shared by the city health department.

Story continues below Advertisement

India has logged 653 cases of the Omicron variant across 21 states and UTs so far, out of which 186 people have recovered or migrated, showed the Union Health Ministry data updated on Tuesday.

Maharashtra recorded the maximum number of 167 such cases followed by Delhi at 165, Kerala 57, Telangana 55, Gujarat 49 and Rajasthan 46.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show